Skip to the page

Data / Form D filings / California Compounding Company, Inc.

California Compounding Company, Inc.: Form D filing

California Compounding Company, Inc., a pharmaceuticals company in Los Angeles, CA, filed a Form D with the SEC in 2026. The latest, on May 12, 2026, reports $4.9 million sold of a $14.5 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6600 W. SUNSET BLVD SUITE 237, Los Angeles, CA, 90028
Phone
(408) 706-6302
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2134601

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 12, 2026New notice$14,520,001$4,923,273$9,596,7284May 1, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Justin LyleExecutive Officer, DirectorChief Executive Officer
Alex FerrieraExecutive Officer, DirectorChief Operating Officer and Corporate Secretary
Tyler TarrExecutive OfficerChief Financial Officer and Treasurer

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of May 11, 2026 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what California Compounding Company, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.